Ra Pharmaceuticals
Acquired
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2008
- Business Model
- B2B
- Website
- rapharma.com
- Last Round
- Series BJul 2015
About
Ra Pharmaceuticals was a Cambridge, Massachusetts-based clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics targeting the complement system to treat rare and severe diseases. The company's lead asset zilucoplan targeted generalized myasthenia gravis. Ra Pharmaceuticals was acquired by UCB for approximately $2.1 billion in April 2020.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account